-
Most Recent
Search Results
240 results for ANV
There Is No Alternative: Why Gold Could Hit $10,000 by 2030
Let’s break down those alternatives and discuss why they’re not viable right now. Then, I’ll tell you how to pair gold stocks with the next…
From “Ridiculous” to Revolutionary: The Tech Shift Investors Can’t Ignore
Today, we asked Marc Chaikin to revisit a fascinating moment in tech history — and explain what it reveals about today’s market setup. His perspective…
Circle These Dates: The Market’s Next Big Windows
As we head deeper into 2026, understanding specific market patterns may matter far more than any resolution you made a few weeks ago.
This Breakthrough Changed Everything – and Most Investors Missed It
Yesterday, we shared Marc Chaikin’s thoughts on how investors can fall behind when markets change and old strategies stop working. Today, he’s taking that idea…
Bitcoin’s Big Problem: It Behaves Like a Tech Stock
Today, we’ll get into why Bitcoin increasingly behaves like a risk asset rather than a safe-haven portfolio hedge. Then, I’ll share one safer, more effective…
Here Is Where Gold Goes Next
What history suggests is next for gold… horrific forecasts of government fiscal excess… a moonshot trade idea from Jonathan Rose… Marc Chaikin’s warning to investors…
Rare Earth Stocks: 7 Critical Questions About Project Vault and the Mining Boom
President Trump’s $12 billion Project Vault sent rare earth stocks soaring. Which mining companies could benefit? Get answers to 7 critical investor questions.
The Devon-Coterra Merger: 7 Key Questions Answered
Devon Energy’s merger with Coterra creates a $58 billion energy giant with a 31% dividend increase. Learn what the all-stock deal means for DVN investors,…
The Great Tech Dislocation – and What Happens Next
In today’s Market 360, I want to walk you through what really happened this week… why the selloff is less about extinction and more about…
Stock Seasonality 2026: The Exact Days to Buy and Sell
TradeSmith analyzed 2 quintillion data points to find the best stock seasonality patterns to buy any stock. See why patterns persist through chaos – and…
2 Stocks to Buy for AI’s Next Stage
Instead, the big winners of the iPhone revolution turned out to be those providing experiences on top of these smartphone systems. Ride-hailing firm Uber, former…
The Market Is Getting More Selective – 202 Stocks Just Changed Grades
If you watched the Super Bowl on Sunday, you already know it ended with the Seattle Seahawks taking home the Lombardi trophy. And while there…
The AI Stocks to Sell Immediately… and the Ones to Buy Instead
In today’s Smart Money, Tom Yeung will share why the biggest spenders will not be the biggest winners. Instead, the winners will be companies weaving…
Why SanDisk Stock Skyrocketed: 5 Key Questions Answered
SanDisk stock is up over 1,000% as AI data centers drive flash memory demand. Learn what’s fueling the rally, the risks ahead, and if SNDK…
Warsh Tapped for Fed Chair – Metals Crash 27%
Kevin Warsh gets the nod for Fed Chair… the market’s reaction… precious metals finally correct – get ready to buy… new data about our ever-expanding…
It’s Over for Bitcoin…for Now
Luke Lango says Bitcoin has hit its Fourth Bust… a “growing consensus” about the government and your wallet… Eric Fry’s pick crushes Nvidia… where to…
Why the Mag 7 Lost $950B in One Week
Last week’s tech chaos explained… why Alphabet and Amazon’s spending shocked Wall Street… the Stage 1 to Stage 2 transition… which stocks face existential threat…
SaaSmageddon Is Here – and Not All Software Stocks Will Survive
An explanation of why software stocks – especially SaaS – are being structurally disrupted by AI, and how investors can identify survivors.
ANVS Stock: The Huge News Sending Annovis Bio Rocketing 200% Today
A dual Alzheimer’s-Parkinson’s clinical trial is showing highly optimistic results for Annovis, and ANVS stock is up huge because of it.
ANVS Stock: The Alzheimer’s Drug News That Has Annovis Bio Plunging Today
Shares of ANVS stock are plummeting on Thursday after Annovis Bio reported weak results from two clinical trials for its leading drug.
Why Is Annovis Bio (ANVS) Stock Up 12% Today?
Annovis Bio (ANVS) stock is getting a boost on Thursday following news that the company will proceed with its Alzheimer’s clinical trial.
Why Did Annovis Bio (ANVS) Stock Close Up 80% Today?
ANVS stock closed up more than 75% today after Annovis announced encouraging clinical trial results for its Parkinson’s drug, buntanetap.
Company Layoffs Accelerate While Fed Stays Silent
In this week’s Navellier Market Buzz, I explained the fears behind the recent layoffs, what’s causing the massive trade deficit and why gold could reach…
Annovis Bio (ANVS) Stock Soars 6% on Positive FDA Update
Annovis Bio (ANVS) stock is soaring higher on Thursday following a positive update from the FDA for its buntanetap clinical trial.
2 – 10 of 240 results
